Sumitomo Mitsui Trust Group Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 06:09 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group Inc. | 39,276 0.850% |
-251,904 (-86.51%) |
Filing |
| 2021-02-05 06:10 am Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group Inc. | 291,180 6.380% |
9,931 (+3.53%) |
Filing |
| 2020-09-09 06:03 am Sale |
2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group Inc. | 281,250 6.300% |
-132,412 (-32.01%) |
Filing |